標(biāo)題: Titlebook: Difficult Decisions in Thoracic Surgery; An Evidence-Based Ap Mark K. Ferguson (Professor and Head) Book 20071st edition Springer-Verlag Lo [打印本頁] 作者: 街道 時(shí)間: 2025-3-21 19:54
書目名稱Difficult Decisions in Thoracic Surgery影響因子(影響力)
書目名稱Difficult Decisions in Thoracic Surgery影響因子(影響力)學(xué)科排名
書目名稱Difficult Decisions in Thoracic Surgery網(wǎng)絡(luò)公開度
書目名稱Difficult Decisions in Thoracic Surgery網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Difficult Decisions in Thoracic Surgery被引頻次
書目名稱Difficult Decisions in Thoracic Surgery被引頻次學(xué)科排名
書目名稱Difficult Decisions in Thoracic Surgery年度引用
書目名稱Difficult Decisions in Thoracic Surgery年度引用學(xué)科排名
書目名稱Difficult Decisions in Thoracic Surgery讀者反饋
書目名稱Difficult Decisions in Thoracic Surgery讀者反饋學(xué)科排名
作者: 催眠 時(shí)間: 2025-3-21 23:24 作者: 琺瑯 時(shí)間: 2025-3-22 02:59 作者: 萬花筒 時(shí)間: 2025-3-22 05:53 作者: exhilaration 時(shí)間: 2025-3-22 10:04
Decision Analytic Techniquesiated social sciences research. This research has certainly played a key role in the tremendous improvement of health throughout the world. It has also complicated decision making, both at the individual and at the policy level, by presenting clinicians with an increasing number of medical technolog作者: 公豬 時(shí)間: 2025-3-22 14:56 作者: 公豬 時(shí)間: 2025-3-22 18:24
How Patients Make Decisions with Their Surgeons: The Role of Counseling and Patient Decision Aidscision quality. Following standard counseling, patients’ score D on knowledge tests and F on their understanding of the probabilities of benefits and harms. Moreover, there is a mismatch between the benefits and harms that patients’ value most and the option that is chosen. Patients participate in d作者: Ingredient 時(shí)間: 2025-3-22 23:33 作者: Enliven 時(shí)間: 2025-3-23 05:13
Routine Mediastinoscopy for Clinical Stage I Lung Cancernvasive diagnostic procedure that has been shown to have a morbidity rate of 1.7%, a mortality rate of 0.07%, and an emergency thoracotomy rate of 0.12%. Most commonly, it is done after noninvasive staging modalities have demonstrated no advanced disease, and is the final step in the determination o作者: 生意行為 時(shí)間: 2025-3-23 09:00 作者: 不如屎殼郎 時(shí)間: 2025-3-23 10:39 作者: deactivate 時(shí)間: 2025-3-23 14:25
Induction Therapy for Stage IIIA (N2) Lung Cancerion of patients into potentially resectable and unresectable categories. This dividing line was set between stage IIIA and stage IIIB disease with contralateral lymph node metastases or local involvement of unresectable or marginally resectable structures defining the limits of surgical treatment. t作者: 文字 時(shí)間: 2025-3-23 20:26
Adjuvant Postoperative Therapy for Completely Resected Stage I Lung Cancerservational studies shows that surgery offers patients the highest cure rate. Nevertheless, following lobectomy or pneumonectomy and mediastinal lymph node staging as standard therapy, only a 67% 5-year survival for stage IA (T1N0) and a 57% 5-year survival for stage IB (T2N0) is expected, with most作者: conservative 時(shí)間: 2025-3-24 01:01
Sleeve Lobectomy Versus Pneumonectomy for Lung Cancer Patients with Good Pulmonary Functionmanagement of centrally located tumors. Initially, surgical therapy of central tumors consisted of pneumonectomy as the only surgical option with favorable outcomes. However, parenchymalsparing procedures, such as sleeve lobectomy, were subsequently described for patients unable to tolerate pneumone作者: conscience 時(shí)間: 2025-3-24 03:08 作者: 一夫一妻制 時(shí)間: 2025-3-24 10:03
Lesser Resection Versus Radiotherapy for Patients with Compromised Lung Function and Stage I Lung Cafortunately, a substantial subset of patients diagnosed with early-stage NSCLC suffer from cardiopulmonary disease and/or other underlying medical comorbidities, and therefore are not suitable candidates for standard therapy. Treatment options for patients unable to tolerate lobectomy are typically 作者: 絕食 時(shí)間: 2025-3-24 14:31
Resection for Patients Initially Diagnosed with N3 Lung Cancer after Response to Induction Therapyes are present at the time of diagnosis. N3 lung tumors have been included in stage IIIB since 1986, when it appeared clear that such locally advanced disease needs to be grouped in a separate stage III category because of the extremely poor prognosis. In the large series reported by Mountain, 5-yea作者: 驚呼 時(shí)間: 2025-3-24 16:26 作者: 玉米 時(shí)間: 2025-3-24 22:27
Surgery for Non-Small Cell Lung Cancer with Solitary M1 Diseaseis chemotherapy or palliative care. A small percentage of patients with newly diagnosed and untreated stage IV disease are found to have a solitary synchronous site of extrathoracic disease, and a small number of patients who have undergone curative resections of intrathoracic disease experience met作者: misanthrope 時(shí)間: 2025-3-25 02:47
Induction Therapy for Stage IIIA (N2) Lung Cancerreatment. The advent of modern cancer therapy with multimodality approaches including surgery, chemotherapy, and radiation therapy has raised significant questions that are still not completely resolved as to the best approach for patients with potentially resectable stage IIIA (N2) disease at presentation.作者: 土坯 時(shí)間: 2025-3-25 06:53 作者: 嘲弄 時(shí)間: 2025-3-25 11:15 作者: 披肩 時(shí)間: 2025-3-25 15:16
apter contains a standard algorithm illustrating the decisioWhy do thoracic surgeons need training in decision making? Many of us who have weathered harrowing residencies in surgery feel that, after such experiences, decision making is a natural extension of our selves. While this is no doubt true, 作者: 歡騰 時(shí)間: 2025-3-25 19:15
Sigmar Puchert,Deutsche Telekom AGnt likelihood of developing recurrent disease after treatment and ultimately dying of their disease. The 5-year survival for patients presenting with clinical stage I lung cancer ranges from 38% to 61%; for those with pathological stage IA disease, the survival is 67%.作者: Chronic 時(shí)間: 2025-3-25 20:42 作者: annexation 時(shí)間: 2025-3-26 00:55 作者: Explosive 時(shí)間: 2025-3-26 07:31
Kultur als Lebenswelt und soziale Praxisregret, and the tendency to blame their doctor for bad outcomes. The underlying mechanisms explaining the poor decision quality with standard counseling is (1) patients’ difficulties recalling facts and understanding probabilities and (2) surgeons’ difficulties judging the values that patients’ place on benefits versus harms.作者: stratum-corneum 時(shí)間: 2025-3-26 12:11 作者: 追蹤 時(shí)間: 2025-3-26 15:58
https://doi.org/10.1007/978-3-642-59548-6these results, patients who a re found to have N2 nodal metastasis prior to thoracotomy, using methods such as mediastinoscopy, thoracoscopy, endoscopic ultrasonography, transbronchial needle aspiration, or possibly positron emission tomography (PET) scanning, should receive neoadjuvant treatment prior to resection.作者: 極肥胖 時(shí)間: 2025-3-26 19:35
https://doi.org/10.1007/978-3-322-86188-7nadequate cardiopulmonary function stimulated the use of parenchymal-sparing procedures for patients with adequate pulmonary function. Increasing clinical evidence suggests that short-term outcomes for sleeve lobectomy are similar to those for pneumonectomy, regardless of cardiopulmonary reserve.作者: Alienated 時(shí)間: 2025-3-26 23:42
https://doi.org/10.1007/978-3-322-86188-7ternal beam radiotherapy. Newer approaches including stereotactic radiosurgery and radiofrequency ablation are now utilized with increasing frequency. Recently, brachytherapy has been introduced as an adjuvant to wedge resection.作者: Cocker 時(shí)間: 2025-3-27 02:53
https://doi.org/10.1007/978-3-658-00137-7 effectively treated by resection of both the primary tumor and the metastasis. Most of these studies have reported patients with cerebral or adrenal metastases, although there are reports describing the surgical management of metastases to the small bowel, spleen, skeletal muscle, and bone.作者: Jingoism 時(shí)間: 2025-3-27 09:13 作者: 可用 時(shí)間: 2025-3-27 11:38
Decision Analytic Techniques about the effect of a medical intervention on patients with specific characteristics. Furthermore, an additional critical step involves integrating population level evidence about outcomes with patient-level values for these outcomes in order to produce individualized care.作者: Coronary 時(shí)間: 2025-3-27 16:41 作者: 滑動(dòng) 時(shí)間: 2025-3-27 18:11 作者: nostrum 時(shí)間: 2025-3-28 01:43
Management of Unexpected N2 Disease Discovered at Thoracotomythese results, patients who a re found to have N2 nodal metastasis prior to thoracotomy, using methods such as mediastinoscopy, thoracoscopy, endoscopic ultrasonography, transbronchial needle aspiration, or possibly positron emission tomography (PET) scanning, should receive neoadjuvant treatment prior to resection.作者: 洞穴 時(shí)間: 2025-3-28 04:40
Sleeve Lobectomy Versus Pneumonectomy for Lung Cancer Patients with Good Pulmonary Functionnadequate cardiopulmonary function stimulated the use of parenchymal-sparing procedures for patients with adequate pulmonary function. Increasing clinical evidence suggests that short-term outcomes for sleeve lobectomy are similar to those for pneumonectomy, regardless of cardiopulmonary reserve.作者: esthetician 時(shí)間: 2025-3-28 09:16
Lesser Resection Versus Radiotherapy for Patients with Compromised Lung Function and Stage I Lung Caternal beam radiotherapy. Newer approaches including stereotactic radiosurgery and radiofrequency ablation are now utilized with increasing frequency. Recently, brachytherapy has been introduced as an adjuvant to wedge resection.作者: 商業(yè)上 時(shí)間: 2025-3-28 10:52 作者: STELL 時(shí)間: 2025-3-28 17:47 作者: 大炮 時(shí)間: 2025-3-28 19:44
Werte und Ziele der ?Neuen Ordnung“e of authors and practicing clinicians. In general, papers addressing the value of a procedure have retrospectively included all patients who underwent the procedure, and not defined the characteristics of the patients.作者: resistant 時(shí)間: 2025-3-29 01:24
https://doi.org/10.1007/978-3-663-02888-8neumonectomy. Traditionally, efforts to improve survival and decrease local recurrence following lung resection for NSCLC have consisted of adjuvant chemotherapy and radiation therapy alone or in combination.作者: minimal 時(shí)間: 2025-3-29 04:05 作者: 鞭打 時(shí)間: 2025-3-29 10:57
Radiographic Staging of Lung Cancer: Computed Tomography and Positron Emission Tomographye of authors and practicing clinicians. In general, papers addressing the value of a procedure have retrospectively included all patients who underwent the procedure, and not defined the characteristics of the patients.作者: 使激動(dòng) 時(shí)間: 2025-3-29 14:05
Adjuvant Postoperative Therapy for Completely Resected Stage I Lung Cancerneumonectomy. Traditionally, efforts to improve survival and decrease local recurrence following lung resection for NSCLC have consisted of adjuvant chemotherapy and radiation therapy alone or in combination.作者: 愉快嗎 時(shí)間: 2025-3-29 19:24 作者: cylinder 時(shí)間: 2025-3-29 22:06 作者: ETCH 時(shí)間: 2025-3-30 02:58
https://doi.org/10.1007/978-3-663-02888-8reatment. The advent of modern cancer therapy with multimodality approaches including surgery, chemotherapy, and radiation therapy has raised significant questions that are still not completely resolved as to the best approach for patients with potentially resectable stage IIIA (N2) disease at presentation.作者: 我要威脅 時(shí)間: 2025-3-30 06:11 作者: Mirage 時(shí)間: 2025-3-30 09:17
https://doi.org/10.1007/978-3-658-00137-7ure, and 36% thought it was unacceptable. The reasons are manifold. Perhaps most importantly, because lung cancer is the most common indication for performing lobectomy, the question of adequacy of the operation in satisfying surgical oncologic principles remains a hurdle in many surgeons’ minds.作者: Injunction 時(shí)間: 2025-3-30 13:33
Auswertung der Qualitativen Interviewstudieation revealed no evidence for coronary artery disease, congestive heart failure, or pneumonia. A chest radiograph demonstrated a large air-fluid level posterior to her heart shadow, a finding that all thoracic surgeons recognize as being consistent with a large paraesophageal hiatal hernia. The pat作者: languor 時(shí)間: 2025-3-30 17:35
Kultur als Lebenswelt und soziale Praxislinical epidemiology at McMaster University in Canada. The concepts associated with this approach have been widely disseminated and described by many as a paradigm shift. Others, however, have debated the usefulness of this approach.作者: Assault 時(shí)間: 2025-3-30 20:48
Auswertung der Qualitativen Interviewstudieiated social sciences research. This research has certainly played a key role in the tremendous improvement of health throughout the world. It has also complicated decision making, both at the individual and at the policy level, by presenting clinicians with an increasing number of medical technolog作者: 商店街 時(shí)間: 2025-3-31 02:24 作者: RUPT 時(shí)間: 2025-3-31 08:23
Kultur als Lebenswelt und soziale Praxiscision quality. Following standard counseling, patients’ score D on knowledge tests and F on their understanding of the probabilities of benefits and harms. Moreover, there is a mismatch between the benefits and harms that patients’ value most and the option that is chosen. Patients participate in d作者: AGGER 時(shí)間: 2025-3-31 11:49
Werte und Ziele der ?Neuen Ordnung“ications on the subject. Part of the confusion arises from the multiplicity of available tests, but more importantly from the fact that the question to be addressed varies in different patient groups. There are different subgroups of patients, particularly with respect to mediastinal staging. The pa作者: escalate 時(shí)間: 2025-3-31 14:49
Rechtsradikalismus im Nachkriegsdeutschlandnvasive diagnostic procedure that has been shown to have a morbidity rate of 1.7%, a mortality rate of 0.07%, and an emergency thoracotomy rate of 0.12%. Most commonly, it is done after noninvasive staging modalities have demonstrated no advanced disease, and is the final step in the determination o作者: 簡(jiǎn)潔 時(shí)間: 2025-3-31 18:09
https://doi.org/10.1007/978-3-642-59548-6reoperative chemoradiotherapy followed b y resection improves long-term and disease-free survival compared with surgery alone. These results have bolstered the interest in multimodality treatment for patients with resectable N2 disease. Furthermore, the literature suggests that neoadjuvant therapy f作者: 性滿足 時(shí)間: 2025-4-1 01:43
Sigmar Puchert,Deutsche Telekom AGtients presenting with localized disease have the best chance of being cured, they represent a minority of patients and unfortunately have a significant likelihood of developing recurrent disease after treatment and ultimately dying of their disease. The 5-year survival for patients presenting with 作者: harangue 時(shí)間: 2025-4-1 02:01
https://doi.org/10.1007/978-3-663-02888-8ion of patients into potentially resectable and unresectable categories. This dividing line was set between stage IIIA and stage IIIB disease with contralateral lymph node metastases or local involvement of unresectable or marginally resectable structures defining the limits of surgical treatment. t
